Strong order book, margin pressure: growth over profits near-term
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 7/10
Grade B
Reaffirmed FY27 growth (25-30%) and margin (25%) guidance despite Q2 margin miss (21.8% delivered vs 25% guided). Huron on track to ₹300-325 Cr; capex acceleration shows commitment. Mixed: near-term margin pressure unresolved.
Cautiously Optimistic
next 1–2 quarters
Very Optimistic
multi-year
Strong multi-year growth backed by ₹5,082 Cr order book and strategic capacity expansion, but Q2 PAT decline of -15.1% despite +18.5% revenue growth signals near-term margin stress from product mix shift and capex investment. Guidance (25-30% growth, 25% margin) is maintained but requires H2 execution to recover margins and deliver Huron contribution. Risk: supply chain delays (Japan CNC controller dependency) and A&D order softness.
₹602 Cr
Revenue · +18.5% YoY₹72.6 Cr
Reported PAT · −15.1% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
31% revenue growth in Q2 FY27 (standalone)
OVERSTATEDConsolidated 18.5% YoY (₹602 Cr vs ₹508 Cr). Standalone figures not independently verified; standalone 31% claim appears inflated vs consolidated growth.
EBITDA margin 28% (standalone Q2); will achieve 25% FY27 consolidated
OVERSTATEDQ2 consolidated margin 21.8%; standalone ~28%. For 25% FY27 avg, H2 needs ~27%. Not yet achieved.
1,900 machines dispatched in Q2, highest ever; order book ₹5,082 Cr
METMachine sales ₹1,802 Cr (entry) + 98 mid + 11 high-end. Order book figure stated directly on call; no contradictory evidence.
PAT ₹115 Cr standalone with 19.6% margin; consolidated ₹73 Cr with 12% margin
METDelivered ₹72.6 Cr PAT consolidated (12% margin). Standalone 19.6% confirmed. Consolidation drag (Huron, acquisition items) explains gap.
Will grow 25-30% for next 2-3 years; maintain 25% margin
METBacked by ₹5,082 Cr order book. Q2 showed 18.5% revenue growth but -15.1% PAT decline, driven by margin compression and capex investment. Growth claim credible; margin recovery requires mix shift & capex maturation.
Earnings quality
What changed since the last call
Capex guidance raised
UpgradePrior ₹200-250 Cr FY27 → now ₹450-500 Cr. Driven by PLI subsidy (₹255 Cr available) and accelerated foundry/electronics buildout. Strategic, not emergency spend.
Product mix shift to entry-level
NewEntry-level machines ₹1,802 Cr (67% of revenue, +46% YoY) vs ₹1,237 Cr prior. Lower margin but higher volume; margin compression from 28% standalone to 21.8% consolidated is result.
A&D order slowdown
DowngradeAerospace/defence orders declined materially Q2. Management attributes to government tender delays and import license clarification timelines. Expects recovery Q3-Q4 as approvals flow.
Huron contribution timeline
NeutralQ2 Huron revenue ₹44 Cr (low); ramp expected Q3-Q4 FY27. Full-year ₹300-325 Cr guidance maintained, but weighted to H2. No surprise; phased integration as expected.
Supply chain risk elevated
NewJapan CNC controller supply constrained; order book intake is 60% dependent on imports (Japan 60% clocked Y-o-Y but supply-delayed). Yen depreciation has made pricing expensive. Risk to execution near-term.
The Q&A
Q&A showed strong analytical push on margins, Huron profitability, and capex payback. Management was direct on numbers but somewhat defensive on control supply-chain risks and A&D slowness timing. Analysts pressed hard on margin recovery (will H2 hit 25%?), and management held firm but offered no new detail. Tone: confident but not dismissive of risks.
Order intake guidance — Harshit Patel, Equirus Securities
AnsweredAlready on track to exceed guidance. Second half is intake month; expecting further orders. Healthy pipeline across sectors. Very confident on delivery.
Interest cost decline — Harshit Patel, Equirus Securities
AnsweredWorking capital utilization driven by capex ramp and working capital optimization. Short-term borrowing cost reduction, not capex capitalization.
Huron profitability — Harshit Patel, Equirus Securities
PartialHuron ₹44 Cr revenue in Q2 with ~₹15 Cr net profit (not ₹43 Cr). Still early in integration; higher margins as ramp-up benefits. Maintaining ₹300-325 Cr FY27 at 8-10% margin guidance.
Entry-level machine margin drag — Bajraag Bafna, Sunidhi Securities
PartialEntry-level product number will increase in H2 (capacity ramp), but so will high-end (defense, aerospace). Will maintain 25% guidance through mix optimization and MTX 100 ramp (higher margin). Entry-level margin floor is 25%; overall will be maintained.
Margin recovery path — Bajraag Bafna, Sunidhi Securities
PartialEntry-level machine dispatches ramping, but also high-end. Consolidation impact from Huron. H2 has better visibility on high-end and Huron ramp. Confident to reach 25%.
Aerospace & defence decline — Aniket Jain, Anand Rathi
AnsweredA&D: government tenders delayed, not cancelled. Orders coming via tenders; some in progress, approvals pending. Expect sharp pickup Q3-Q4. Auto/general engineering strong; is the lever for us. No risk there.
French Huron investigation status — Ajay Surya, Niveshaay
DodgedReceived notice April 2026; no communications since. Likely routine investigative process (same as other companies). No direct business impact. Design/IP ownership with Jyoti; no supply chain risk.
CNC controller supply chain — Ajay Surya, Niveshaay
AnsweredJapan controller supply clocked 60% Y-o-Y growth but yen depreciation made pricing expensive. Order book delivery planned; renting capacity off. Electronics/controllers in-house being developed (200+ engineers in R&D center). Confident on execution.
Order book realization — Raj Shah, ENAM AMC
AnsweredOrder book is strong; H1 clocked ₹1,900 machines. H2 expected to be better given capacity coming in. Very confident in next 3 years; visibility is there. All sectors Tier 1, Tier 2, Tier 3.
EMS (entry-level machine) order delays — Raj Shah, ENAM AMC
AnsweredNew capacity already into execution. Ramp-up will happen Q3-Q4. EMS improvement visible; execution has also improved. Expecting further improvement in next 2 quarters.
Capex timeline and targets — Rajesh Nikhil Kanodia, Sunidhi Securities
PartialFoundry at final stages; starting this quarter. Equipment under transit, complete by month-end. All capex budgeted at ₹450-500 Cr over 5 years; phased spend via PLI subsidy (₹255 Cr). Payback from margin improvement and volume growth.
FY27 machine guidance — Rajesh Nikhil Kanodia, Sunidhi Securities
AnsweredYes, 4,700 is achievable. Already done 3,317; expecting strong Q3-Q4. Capacity ramp will drive this. 8,000 target is 90% done in 6 months.
Machine realization decline — Aniket Jain, Anand Rathi
PartialMix shift to entry-level machines (lower realization ₹32-35 Cr). As high-end ramps (defense, aerospace), realization will improve. Confident range will be ₹35-36 Cr in next 2-3 years.
Competition and pricing pressure — Sanjay Ladha, Bastion Research
AnsweredMarket share erosion from 80% imports to 38% over 10 years. Now competing locally. Our advantage: 40k+ machines installed, customer base, domestic presence. Capabilities increasing, demand strong. Not seeing sharp price competition; we're competing on capability not price.
Huron revenue ramp and profitability — Abhishek Jain, Kriis PMS
AnsweredAbsolutely. Will cover in H2. Right now early-stage ramp; margins expected to improve as scale increases. Will add positively to consolidated EBITDA margins in H2.
H1 vs H2 guidance — Sanjay Ladha, Bastion Research
PartialH1 was lower; H2 will be much better. Huron ramp, capacity utilization, and high-end machines will drive H2. Expecting 70-75% of PAT in H2; 60%+ EBITDA. Not conservative.
Foundry ramp and production — Nikhil Kanodia, Sunidhi Securities
AnsweredNew foundry is new technology (lost-foam casting). Equipment under transit; complete by month-end. Ramp to happen Q3-Q4. No bottleneck; all commissioned and ready to use.
Guidance
FY27 consolidated growth 25-30% vs FY26
HighOrder book ₹5,082 Cr provides visibility. H1 growth 18.5% YoY; H2 acceleration expected from Huron ramp, capacity utilization, and order conversion. On track.
FY27 EBITDA margin 25% (consolidated target)
MediumQ2 delivered 21.8%; H2 needs ~27% to average 25%. Entry-level machine margin floor is 25%; high-end mix improvement and Huron ramp expected to recover. Achievable but execution-dependent.
Huron FY27 EBITDA margin 8-10%
MediumQ2 Huron is early-stage (₹44 Cr revenue). As production ramps Q3-Q4, margins expected to improve toward 8-10% range. Conservative but unproven.
FY27 capex ₹450-500 Cr (raised from ₹200-250 Cr prior)
HighPLI subsidy (₹255 Cr available) funding electronics/controllers manufacturing and foundry expansion. ₹183 Cr spent; ₹267-317 Cr remaining. Foundry commissioning Q3-Q4 FY27.
Risks the call surfaced
Supply chain concentration
HighJapan machine tool order book is 60% of total; yen depreciation increased costs and tightened supply. Delays cascade to EMS order execution. Partially mitigated by in-house controller development (PLI-funded), but 2-3 year timeline.
Margin compression from product mix
HighEntry-level machines (₹1,802 Cr, 67% of Q2 revenue) carry 22-25% margin vs 28%+ for high-end. Mix shift to entry-level driven by auto/general engineering demand for lower-cost options. If this persists, consolidated margin will stay below 25% target.
Aerospace & Defence order volatility
MediumA&D orders declined Q2; management attributes to government tender process delays and import license clarifications for defense manufacturing. Represents 21% of Q2 revenue. Recovery dependent on government approval timelines (Q3-Q4 assumed but not guaranteed).
Capex execution & cost inflation
MediumFoundry using new technology (lost-foam casting); equipment sourcing and commissioning carry cost/schedule risk. Electronics controllers development (110+ engineers, R&D-heavy) requires sustained spending. Cost overruns or delays could reduce margin uplift and extend payback timeline.
Huron integration execution
MediumHuron contributed only ₹44 Cr in Q2 FY27; needs ~₹250+ Cr in H2 to hit ₹300-325 Cr FY27 guidance. French government investigation status unclear (no updates since April 2026 notice). While management says routine, any escalation could disrupt supply chain or IP ownership clarity.
Management
Score 7/10. Clear on financials and order book, but somewhat evasive on supply chain risks and margin recovery timeline. Direct on numbers; hedged on execution timelines. Met FY27 order book and machine dispatch targets (₹800 Cr Q2 intake, 1,911 machines). Capex execution on track (₹183 Cr spent, foundry completion imminent). Margin recovery target (25% FY27) at risk based on Q2 delivery (21.8%).
1 · Q3 & Q4 FY27
Huron production ramp-up expected; ₹300-325 Cr FY27 target on track (₹44 Cr in Q2, need ₹250+ Cr in H2)
2 · Q3 & Q4 FY27
Foundry capacity live (new capacity taking throughput from 1.5k to 5k tpm/month); MTX 100 5-axis machine dispatches begin
3 · H1 FY28
Electronics/controllers in-house manufacturing ramp (PLI subsidy funded ₹1,020 Cr over 5 years); reduces import dependency, improves margins
Risk: supply chain delays (Japan CNC controller dependency) and A&D order softness.
Informational and educational content only. Not investment advice.